Open Orphan Share Discussion Threads

[trader_3] 02/2/2021 08:31

Green - the advert was posted yesterday & closes on 140221

[greenelf] 02/2/2021 08:27

Old. 2nd Feb today.

[trader_3] 02/2/2021 08:21

New hVIVO Recruitment - 10 x Clinical Site Specialist, starting end of January

‘I am looking for 10 biomedical graduates, to work a 6-month contract for Hvivo, starting end of January.

Job title: Clinical Site Specialist (CSS)

London’

hxxps://www.biomedicalscientistjobs.co.uk/job/1558/clinical-site-specialist/?TrackID=21&utm_campaign=Biomedical+Main+site

New hVIVO recruitment for 10 more positions, on top of the current recruitment.

Something’s brewing and I think it smells good!

[bobsworth] 01/2/2021 23:49

Interesting Tweet from Eskers! ?

Eskers
@Eskers1
·
6h
#ORPH
Hold on a minute....
That's a Flucamp banner going onto the side of the Whitechapel Hotel.
A hotel with 27 bedrooms and immediately opposite the existing 24 bed quarantine facility in East London...
Could this be the 3rd facility!?

NB! Hotel now not taking booking until 2024!!!

[slartybartfaster] 01/2/2021 23:06

So where have they gone? The share price is holding up well in the face of it. It's a strong consolidation phase.

[klosters65] 01/2/2021 22:55

Different people contribute in different ways.We need a chuckle to keep our sanity and to remind us, it is not the end of the planet hopefully if the shares that we are invested in go down.

[ross k] 01/2/2021 22:35

Although you add nothing of substance to this tread.But this made me chuckle

[orphan1] 01/2/2021 22:17

Beep Beep Sorry fokes the damn engine is giving a little issue atm, American built I believe, tut tut We should be leaving this damn 23 platform shortly Thank you for your patienceYours sincerely Orphan

[mark10101] 01/2/2021 21:41

Feels appropriate to me KS.

[king suarez] 01/2/2021 21:23

From May 20 to Sept 20 we had a share graph that looks eerily similar to the one from Oct 20 till now - then it went up 2.5 x to 30p - that would put us up close to 60p if repeated? Might be the top of the next leg up..

[king suarez] 01/2/2021 21:20

Investment funds that have rules around position size and redemption requests most likely - that selling leads to price stagnation, which leads to PIs selling out of fear/frustration, which leads to the price dropping, which is what we have seen - whilst fundamentals get stronger and stronger.

[mark10101] 01/2/2021 21:15

KS, it feels that way to me, coiled spring situation yet again. Who knows why people sell just before re rates but they do....

[king suarez] 01/2/2021 21:08

That was his post at the time, in March 20, when we were £35m.. before the rise from 6p. He's suggesting we're at a similar inflection point?

[sh0wmethemoney] 01/2/2021 20:49

MCAp £155 million not £35 though.

[12toes] 01/2/2021 19:58

520,000 dumped in blocks at the end of the day - "what a surprise" said no one ever This share won't be moving up until the dumping stops

[pierre oreilly] 01/2/2021 19:38

Not entirely sure what the debate was about - i thought it was whether orph have approval to put a live covid virus up someone's nose.

They do have that approval. It's a live covid virus derived from the wild virus by codagenix.

That'll be a different live covid virus used for challenge studies, for which they haven't yet said it's been approved, but, that is just a formality imv. (As are the covid challenge studies themselves - there's no ethical issue which people sometimes go on about on here)

[sh0wmethemoney] 01/2/2021 19:12

The Pathogen is the same it’s the load/scale of it which the Study will determine the minimum amount to cause the infection. I am was not trying to suggest they would be using the wild version, I was just trying to say to Greg a Safety/Immunogenicity study that has been approved won’t be the same as what is needed for the HCS.

[pierre oreilly] 01/2/2021 18:45

smtm, I don't think anyone will ever get a sniff of the unmodified covid virus, if that is what you are saying. The covid challenge studies will use the derivative developed during the characterisation study.

The value in the various challenge study models is largely the modified infective agent.

[mark10101] 01/2/2021 18:06

Well they don’t seem to have a lot of availability going forward.....

[sh0wmethemoney] 01/2/2021 18:02

But the Safety and Immunogenicity of COVI-VAC will not include the deliberate use of the Pathogen in its raw form, so in my eyes not the same thing, I think approval will come and hopefully soon.

[systagenix] 01/2/2021 17:49

From Eskers on Twitter